跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 72,321 条关于
“topoisomerase-1 inhibitor”
全部
72,321
临床试验
42,512
药物
10,648
机构
1,397
资讯
17,764
去年
FDA Grants Fast Track Designation to Mersana's Emiltatug Ledadotin for Expanded Breast Cancer Treatment
去年
Zymeworks Receives FDA Clearance for ZW251, Novel Glypican-3 Targeted ADC for Hepatocellular Carcinoma
6个月前
Sanofi-Pfizer CEACAM5 ADC Trial Halted in Europe as Merck KGaA Advances Competing Asset to Phase 3
去年
Tubulis' ADC TUB-030 Enters Phase I/IIa Trial for Advanced Solid Tumors
去年
Merck KGaA's ADC Precemtabart Tocentecan Shows Promising Safety and Efficacy in Metastatic Colorectal Cancer Trial
5个月前
Callio Therapeutics Initiates First-in-Human Trial of Dual-Payload ADC CLIO-8221 for HER2-Positive Solid Tumors
去年
NextCure and Simcere Zaiming Form Strategic Partnership for CDH6-Targeting ADC SIM0505
去年
Pfizer Presents Promising Preclinical Data on Novel Mesothelin-Targeting ADC at AACR 2025
7个月前
Alphamab Advances First PD-L1 x VEGFR2 Antibody-Drug Conjugate JSKN027 Into Clinical Trials
去年
Phase III ATTAIN Trial Assesses Etirinotecan Pegol for Breast Cancer Brain Metastases
第 1 页,共 1777 页
上一页
下一页